Baseline and sociodemographic characteristics of 197 women enrolled into a phase lll microbicide trial in southwestern Uganda (September 2013–December 2014) frequencies, percentages
| Variable | Treatment arm | ||
| n (%) | Dapivirine | Placebo | |
| Overall | 197(100) | 132 (67.0) | 65 (33.0) |
| Age (years) | 25 (38.5) | ||
| 18–24 | 72 (36.6) | 47 (35.6) | 27 (41.5) |
| 25–34 | 82 (41.6) | 55 (41.7) | 13 (20.0) |
| 35–44 | 43 (21.8) | 30 (22.7) | |
| Education | 20 (30.8) | ||
| None | 68 (34.5) | 48 (36.4) | |
| Primary | 105 (53.3) | 45 (49.2) | 40 (61.5) |
| Secondary | 24 (12.2) | 19 (14.4) | 5 (7.7) |
| Marital status | |||
| Married | 82 (41.6) | 57 (43.2) | 25 (38.5) |
| Single | 90 (45.7) | 57 (43.2) | 33 (50.8) |
| Divorced/separated/widowed | 25 (12.7) | 18 (13.6) | 7 (10.8) |
| Occupation | |||
| Bar/hotel | 79 (40.1) | 52 (39.4) | 27 (41.5) |
| Small scale business | 58 (29.4) | 38 (28.8) | 20 (30.8) |
| Saloon/shop | 24 (12.2) | 18 (13.6) | 6 (9.3) |
| Unemployed | 16 (08.1) | 12 (9.1) | 4 (6.2) |
| Other | 20 (10.2) | 12 (9.1) | 8 (12.3) |
| Currently has a main partner | |||
| Yes | 162 (82.3) | 109 (85.6) | 53 (81.5) |
| No | 35 (17.8) | 23 (17.4) | 12 (18.5) |
| Duration lived with sexual partner (years) | |||
| 0–1 | 51 (31.1) | 34 (30.6) | 17 (32.1) |
| 2–5 | 51 (31.1) | 35 (31.5) | 16 (30.2) |
| 6+ | 62 (37.8) | 42 (37.8) | 20 (37.7) |
| Contraception | |||
| Injectable* | 106 (53.8) | 70 (53.0) | 36 (55.4) |
| IUCD | 10 (5.1) | 7 (5.3) | 3 (4.6) |
| Oral pills | 32 (16.2) | 19 (14.4) | 13 (20.0) |
| Implants† | 45 (22.8) | 33 (25.0) | 12 (18.5) |
| Sterilisation | 4 (2.0) | 3 (3.3) | 1 (1.5) |
*Injectable: depot medroxyprogesterone acetate.
†Implants: Norplant and Jadelle.
IUCD, intrauterine contraceptive device.